Are diabetes microvascular complications risk factors for fragility fracture?
- PMID: 33989258
- DOI: 10.1097/MED.0000000000000642
Are diabetes microvascular complications risk factors for fragility fracture?
Abstract
Purpose of review: We describe relationships between microvascular complications and bone fragility fracture in the context of diabetes. We highlight gaps in knowledge and suggest areas of further study.
Recent findings: Evidence in type 1 diabetes (T1D) demonstrates that low bone mineral density (BMD) is associated with microvascular complications and linked to increased fracture risk. Of note, the low BMD does not solely explain bone fragility. Microvascular disease also has been linked to compromised bone microarchitecture and poorer bone quality. Moreover, microvascular complications may indirectly increase the rate of fragility fracture through increasing fall propensity; however, to date no conclusive studies have assessed microvascular disease and fracture risk independent of falls.In the other hand, individuals with type 2 diabetes (T2D) have increased fracture risk despite high BMD. Data suggest microvascular disease mediates microarchitectural changes by increasing cortical porosity and is associated with lower bone turnover. There is no direct evidence linking microangiopathy to fracture incidence.
Summary: Taken together present evidence suggests associations between diabetic bone disease, fragility fracture, and microvascular disease. Data are more convincing for T1D than T2D. Further studies are required to confirm whether microvascular disease is itself causative of fracture or merely a contributory factor to fragility fracture for persons with diabetes.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Knudsen JK, Leutscher P, Sørensen S. Gut microbiota in bone health and diabetes. Curr Osteoporos Rep 2021; Online ahead of print. doi: 10.1007/s11914-020-00629-9. - DOI
-
- Napoli N, Chandran M, Pierroz DD, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 2017; 13:208–219.
-
- Samelson EJ, Demissie S, Cupples LA, et al. Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT Study. J Bone Miner Res 2018; 33:54–62.
-
- Shapiro MR, Wasserfall CH, McGrail SM, et al. Insulin-like growth factor dysregulation both preceding and following type 1 Diabetes diagnosis. Diabetes 2020; 69:413–423.
-
- Romero-Díaz C, Duarte-Montero D, Gutiérrez-Romero SA, et al. Diabetes and bone fragility. Diabetes Ther 2021; 12:71–86.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
